Beyond Air, Inc.

XAIR Nasdaq CIK: 0001641631

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 900 STEWART AVENUE, GARDEN CITY, NY, 11530
Mailing Address 900 STEWART AVENUE, GARDEN CITY, NY, 11530
Phone 516-665-8200
Fiscal Year End 0331
EIN 473812456

Financial Overview

FY2025

-$46.63M
Net Income
$56.96M
Total Assets
$29.77M
Total Liabilities
$-0.69
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 13, 2026 View on SEC
10-Q Quarterly financial report February 13, 2026 View on SEC
8-K Current report of material events February 2, 2026 View on SEC
S-3 Shelf registration for future offerings January 30, 2026 View on SEC
8-K Current report of material events January 20, 2026 View on SEC
8-K Current report of material events January 15, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
3 Initial insider ownership report January 6, 2026 View on SEC
8-K Current report of material events December 30, 2025 View on SEC
DEF 14A Definitive proxy statement December 19, 2025 View on SEC

Material Events

8-K Strategy Change January 15, 2026
High Impact
  • Beyond Air is sharpening its focus on its core nitric oxide (NO) delivery platform and LungFit® product line.
  • The company received $1 million in upfront cash, strengthening its balance sheet.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.